Patent directory · USPTO A61K / A61P
Patents matching “The United States of America”
3,063 pharma patents match "The United States of America" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 3,063 pharmaceutical patents matching "The United States of America" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 12201658
Viral gene therapy as treatment for cholesterol storage disease or disorder
granted -
US 12202886
Neutralizing antibodies to GP120 and their use
granted -
US 12201685
Methods of modulating immune responses with cationic lipid vaccine compositions
granted -
US 12195724
Methods of producing T cell populations enriched for stable regulatory T-cells
granted -
US 12187779
Anti-human papillomavirus 16 E6 T cell receptors
granted -
US 12188005
NK cells with an increased antibody-dependent cellular toxicity (ADCC) against tumors
granted -
US 12186363
Compositions and methods for dengue virus chimeric constructions in vaccines
granted -
US 12178907
Binary lipid bilayer-containing vesicles comprising embedded cytotoxic agents and methods of making and using the same
granted -
US 12180296
Cross species single domain antibodies targeting mesothelin for treating solid tumors
granted -
US 12180484
Chimeric antigen receptors targeting B-cell maturation antigen
granted -
US 12171818
Methods of isolating T cells having antigenic specificity for a cancer-specific mutation
granted -
US 12172038
Anti-coronavirus antibodies and methods of use
granted -
US 12173306
Codon-optimized reduced-size ATP7A CDNA and uses for treatment of copper transport disorders
granted -
US 12168802
Methods of diagnosing and treating CD55 deficiency, hyperactivation of complement, angiopathic thrombosis and protein losing enteropathy (CHAPLE), a newly identified orphan disease
granted -
US 12168675
Virus-like particles and methods of use
granted -
US 12168008
Oxabicycloheptanes for modulation of immune response
granted -
US 12161733
Chemical conjugates of Evans Blue derivatives and their use as radiotherapy and imaging agents for targeting prostate cancer
granted -
US 12162910
Recombinant gp120 protein with V1-loop deletion
granted -
US 12162861
Dopamine D3 receptor selective antagonists/partial agonists; method of making; and use thereof
granted -
US 12157762
Tethered interleukin-15 and interleukin-21
granted -
US 12152242
CRISPR therapy
granted -
US 12145968
Recombinant HIV-1 envelope proteins and their use
granted -
US 12145922
Selective D3 dopamine receptor agonists and methods of their use
granted -
US 12138294
Transgenic corn with antifungal peptide AGM182 (DN:0113.18)
granted